Skip to main content
. 2022 Feb 1;12:811293. doi: 10.3389/fendo.2021.811293

Table 1.

Findings on circulating miRNAs in adrenocortical cancer.

Author and year of publication Sample type Method of miRNA isolation Cohort miRNAs in ACC compared to adenoma or normal adrenal cortices Reference
Chabre et al. (2013) Serum qRT-PCR 23ACC, 14ACA, 19NA miR-483-5p↑, miR-335↓, miR-195↓, miR-139-5p↑, miR-376a↓ (24)
Patel et al. (2013) Serum qRT-PCR 17ACC, 22ACA miR-483-5p↑, miR-34a↑ (39)
Szabo et al. (2014) Plasma qRT-PCR 13ACC, 12ACA miR-100↑, miR-181b↑, miR-184↑, miR-210↑, miR-483-5p↑ (40)
Perge et al. (2017) Plasma-EV qRT-PCR 22ACC, 24ACA miR-101↑, miR-483-5p↑ (41)
Salvianti et al. (2017) Plasma qRT-PCR 27ACC, 13ACA, 10NA miR-483-5p↑ (42)
Perge et al. (2018) Plasma-EV qRT-PCR 9CP-ACC, 13CPA, 13NFA miR-320b↑, miR-27a-3p↑, miR-22-3p↑, miR-210-3p↑ (43)
Decmann et al. (2018) Plasma qRT-PCR 11ACC, 11ACA, 11AML miR-483-3p↑, miR-483-5p↑ (36)
Decmann et al. (2019) Plasma qRT-PCR 23ACC, 23ACA miR-483-5p↑ (44)

↑, up-regulation; ↓, down-regulation; qRT-PCR, quantitative real-time polymerase chain reaction; ACC, adrenocortical carcinoma; ACA, adrenocortical adenoma; AML, adrenal myelolipoma; NA, normal adrenal; EV, extracellular vesicle; CP-ACC, cortisol-producing adrenocortical carcinoma; CPA, adrenocortical adenoma; NFA, non-functioning adrenocortical adenoma.